Transl Clin Pharmacol.  2017 Jun;25(2):59-62. 10.12793/tcp.2017.25.2.59.

Pharmacokinetic variability due to environmental differences

Affiliations
  • 1Department of Pharmacology & Clinical Pharmacology, University of Auckland, Auckland, New Zealand. n.holford@auckland.ac.nz

Abstract

This tutorial describes sources of pharmacokinetic variability that are not obviously linked to genetic differences. The sources of variability are therefore described as environmental. The major quantitative sources of environmental variability are body size (including body composition), maturation and organ function. Size should be considered in all patients. Maturation is mainly relevant to neonates and infants less than 2 years of age. Renal function is the most important predictable source of variability due to differences in organ function.

Keyword

variability; size; maturation; organ function; pharmacokinetics

MeSH Terms

Body Size
Humans
Infant
Infant, Newborn
Pharmacokinetics

Figure

  • Figure 1 Illustration of the difference in size between a child and an adult. Clearance differences are explained by allometric scaling of relative body weight.

  • Figure 2 Allometric size is shown in relation to body weight across the human weight range (0.5 – 250 kg). Note that there is a 500 fold range of weight but allometric size for functional properties of the body only changes about 100 fold.

  • Figure 3 The relationship between post-menstrual age and clearance expressed as a fraction of clearance in a 70 kg adult. GFR,[9] morphine and paracetamol,[10] dexmedetomidine[11] and tramadol.[12]


Cited by  1 articles

Pharmacodynamic principles and target concentration intervention
Nick Holford
Transl Clin Pharmacol. 2018;26(4):150-154.    doi: 10.12793/tcp.2018.26.4.150.


Reference

1. West GB, Brown JH, Enquist BJ. The fourth dimension of life: fractal geometry and allometric scaling of organisms. Science. 1999; 284:1677–1679.
Article
2. Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B. Quantification of lean bodyweight. Clin Pharmacokinet. 2005; 44:1051–1065.
Article
3. Xue L, Holford N, Ding XL, Shen ZY, Huang CR, Zhang H, et al. Theory-based pharmacokinetics and pharmacodynamics of S- and R-warfarin and effects on international normalized ratio: influence of body size, composition and genotype in cardiac surgery patients. Br J Clin Pharmacol. 2017; 83:823–835. DOI: 10.1111/bcp.13157.
Article
4. McCune JS, Bemer MJ, Barrett JS, Scott Baker K, Gamis AS, Holford NH. Busulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: A Population Pharmacokinetic Model for Initial and Bayesian Dose Personalization. Clin Cancer Res. 2014; 20:754–763. DOI: 10.1158/1078-0432.CCR-13-1960.
Article
5. Cortínez LI, Anderson BJ, Penna A, Olivares L, Muñoz HR, Holford NH, et al. Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. Br J Anaesth. 2010; 105:448–456. DOI: 10.1093/bja/aeq195.
Article
6. Holford NHG, Anderson BJ. Allometric size: The scientific theory and extension to normal fat mass. Eur J Pharm Sci. 2017; DOI: 10.1016/j.ejps.2017.05.056.
Article
7. Schwartz GJ. Does kL/PCr estimate GFR, or does GFR determine k? Pediatr Nephrol. 1992; 6:512–515.
Article
8. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130:461–470.
Article
9. Rhodin MM, Anderson BJ, Peters AM, Coulthard MG, Wilkins B, Cole M, et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol. 2009; 24:67–76. DOI: 10.1007/s00467-008-0997-5.
Article
10. Anderson BJ, Holford NHG. Tips and traps analyzing pediatric PK data. Paediatr Anaesth. 2011; 21:222–237. DOI: 10.1111/j.1460-9592.2011.03536.x.
Article
11. Potts L, Anderson BJ, Warman GR, Lerman J, Diaz SM, Vilo S. Dexmedetomidine pharmacokinetics in pediatric intensive care; a pooled analysis. Pediatric Anesthesia. 2009; 19:1119–1129. DOI: 10.1111/j.1460-9592.2009.03133.x.
Article
12. Allegaert K, Holford N, Anderson BJ, Holford S, Stuber F, Rochette A, et al. Tramadol and O-desmethyl tramadol clearance maturation and disposition in humans: a pooled pharmacokinetic study. Clin Pharmacokinet. 2015; 54:167–178. DOI: 10.1007/s40262-014-0191-9.
Article
Full Text Links
  • TCP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr